Deprenyl suppresses the oxidant stress associated with increased dopamine turnover

Annals of Neurology
G Cohen, M B Spina

Abstract

Tissue glutathione disulfide (GSSG) was studied as an index of changes in redox state in the striatum. When increased turnover of dopamine was provoked in mice by injection of haloperidol (1 mg/kg), the concentration of GSSG in the striatum tripled. Deprenyl (2.5 mg/kg) suppressed the rise in GSSG by 71.9%. These results indicate that deprenyl suppresses an oxidant stress associated with increased dopamine turnover.

References

Feb 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·M B Spina, G Cohen
Jun 12, 1987·Science·R Lewin
Feb 10, 1987·Neuroscience Letters·A SlivkaG Cohen
Mar 1, 1971·Journal of Neurochemistry·T L PerryD Lesk
Nov 1, 1980·Journal of Neurochemistry·A J CooperT E Duffy

❮ Previous
Next ❯

Citations

Apr 1, 2003·Annals of Neurology·Fabrizio Stocchi, C Warren Olanow
Sep 1, 1994·Annals of Neurology·J SianC D Marsden
Dec 1, 1991·Journal of Neuroscience Research·W G Tatton, C E Greenwood
Feb 1, 1992·Journal of Neuroscience Research·P T Salo, W G Tatton
Jan 1, 1993·Movement Disorders : Official Journal of the Movement Disorder Society·C W Olanow
Jan 1, 1993·Movement Disorders : Official Journal of the Movement Disorder Society·W G Tatton
Jan 1, 1993·Movement Disorders : Official Journal of the Movement Disorder Society·J O Rinne
Jan 1, 1991·Journal of Neural Transmission. General Section·P DostertE Frigerio
Jan 1, 1992·Journal of Neural Transmission. General Section·A ClowD Dexter
Jan 1, 1995·Journal of Neural Transmission. General Section·S DethyS Goldman
Jan 1, 1995·Journal of Neural Transmission. General Section·R M WuC C Chiueh
Jan 1, 1994·Journal of Neural Transmission. General Section·G SkuzaW Danysz
Jan 1, 1994·Journal of Neural Transmission. Parkinson's Disease and Dementia Section·T BrannanM D Yahr
May 16, 2009·Journal of Neural Transmission·Santhrani Thaakur, G Himabindhu
Oct 15, 1990·Biological Psychiatry·J L Cadet, A S Perumal
Jul 1, 1990·Journal of the Neurological Sciences·B R BloemJ W Langston
Aug 1, 1994·Journal of the Neurological Sciences·Y IwasakiM Kinoshita
Jun 1, 1991·Lancet·C G Clough
Jan 1, 1994·Pharmacology & Therapeutics·M E GötzM B Youdim
Mar 1, 1996·Schizophrenia Research·S P Mahadik, S Mukherjee
Jun 5, 1992·European Journal of Pharmacology·M GerlachM B Youdim
May 12, 2005·Neuroscience Letters·Nazan UysalIlgi Semin
Nov 17, 2001·European Journal of Pharmacology·L SimonZ Nagy
Oct 30, 1998·Journal of Psychiatric Research·D V JesteM P Caligiuri
Apr 30, 1999·Neuropharmacology·S BalijepalliV Ravindranath
Dec 31, 2003·Neurotoxicology·Peter RiedererEdna Grünblatt
Jun 6, 2000·Trends in Neurosciences·R J Jakel, W F Maragos
Jun 1, 1997·Brain Research. Molecular Brain Research·J A Rodríguez-GómezA Machado
Jun 1, 1997·Neurochemistry International·A CastañoA Machado

❮ Previous
Next ❯

Related Concepts

Related Feeds

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here